http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101287712-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c5a5dc7c11cf171ceb132cb13a4045fe
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-22
filingDate 2006-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2012-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_844feabf9ebcbc725acb20d17082df96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ce8236134ac4d5d4c6c09ddffc9fe3c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e06159cf5d6223e0671ce7f84c997173
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91ad515339dca1d5d4c5d587b8dabb3b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f351984de3591dd117835c6268b490c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63c7b7561bb945397324a51c1a434746
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c6add6c82d02a450bbd157608b29370
publicationDate 2012-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-101287712-B
titleOfInvention Heterocyclic compound
abstract The present invention relates to compounds which are inhibitors of histone deacetylases. More specifically, the present invention relates to heterocyclic compounds and methods for their preparation. The compounds are useful as medicaments for the treatment of proliferative disorders, and other diseases involving, relating to or accompanied by enzymes having histone deacetylase (HDAC) activity.
priorityDate 2005-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466114226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419516909
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6944
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57429932
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID157359993
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466308234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466677312
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466674371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467071548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410593316
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466674370
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466907339
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468182646
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447861913
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466907338

Total number of triples: 45.